IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.

IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.

Item
http://www.wikidata.org/entity/Q27692015
Metabolic control of cancer cell stemness: Lessons from iPS cellsMolecular Connections between Cancer Cell Metabolism and the Tumor MicroenvironmentRegistered report: IDH mutation impairs histone demethylation and results in a block to cell differentiationRegistered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarateTERT promoter mutations and telomere length in adult malignant gliomas and recurrences.Functions for diverse metabolic activities in heterochromatin.Metabostemness: a new cancer hallmark.Anaplastic glioma: current treatment and management.Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.Mutational analysis using Sanger and next generation sequencing in sporadic spindle cell hemangiomas: A study of 19 cases.Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging.IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas.
P2860

IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.

Item
http://www.wikidata.org/entity/Q27692015
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@ast
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@en
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@nl
type
label
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@ast
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@en
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@nl
prefLabel
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@ast
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@en
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698